Thassila N Pitanga1,2, Sânzio S Santana1,2, Dalila L Zanette3, Caroline C Guarda1, Rayra P Santiago1, Vitor V Maffili1, Jonilson B Lima4, Graziele Q Carvalho1, Jaime R Filho1, Junia R D Ferreira5, Milena M Aleluia6, Valma M L Nascimento7, Magda O S Carvalho8, Isa M Lyra8, Valéria M Borges1, Ricardo R Oliveira1, Marilda S Goncalves9,10. 1. Instituto Gonçalo Moniz, FIOCRUZ Bahia, Fundação Oswaldo Cruz / FIOCRUZ, Rua Waldemar Falcão, n. 121, Candeal, Salvador, Bahia, 40296710, Brazil. 2. Universidade Católica do Salvador (UCSAL), Salvador, Bahia, Brazil. 3. Fundação Oswaldo Cruz, Instituto Carlos Chagas (ICC-FIOCRUZ/PR), Curitiba, Paraná, Brazil. 4. Universidade Federal do Oeste da Bahia (UFOB), Barreiras, Bahia, Brazil. 5. Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil. 6. Universidade Estadual de Santa Cruz (UESC), Ilhéus, Bahia, Brazil. 7. Fundação de Hematologia e Hemoterapia da Bahia (HEMOBA), Salvador, Bahia, Brazil. 8. Hospital Universitário Professor Edgard Santos (HUPES), UFBA, Salvador, Bahia, Brazil. 9. Instituto Gonçalo Moniz, FIOCRUZ Bahia, Fundação Oswaldo Cruz / FIOCRUZ, Rua Waldemar Falcão, n. 121, Candeal, Salvador, Bahia, 40296710, Brazil. marilda.goncalves@fiocruz.br. 10. Universidade Federal da Bahia (UFBA), Salvador, Bahia, Brazil. marilda.goncalves@fiocruz.br.
Abstract
OBJECTIVE AND DESIGN: This study tested the hypothesis that sickle red blood cell (SS-RBC) can induce inflammasome NLRP3 components gene expression in peripheral blood mononuclear cells (PBMCs) as well as interleukin-1β (IL-1β) and leukotriene B4 (LTB4) production. Additionally, we investigated the effect of hydroxyurea (HU) treatment in these inflammatory markers. METHODS: PBMCs from healthy donors (AA-PBMC) were challenged with intact and lysed RBCs from SCA patients (SS-RBC) and from healthy volunteers (AA-RBC). NLRP3, IL-1β, IL-18 and Caspase-1 gene expression levels were assessed by quantitative PCR (qPCR). IL-1β protein levels and LTB4 were measured by ELISA. RESULTS: We observed that lysed SS-RBC induced the expression of inflammasome NLRP3 components, but this increase was more prominent for CASP1 and IL18 expression levels. Moreover, we observed that intact SS-RBC induced higher production of IL-1β and LTB4 than lysed SS-RBC. Although SCA patients treated with HU have a reduction in NLRP3 gene expression and LTB4 production, this treatment did not modulate the expression of other inflammasome components or IL-1β production. CONCLUSIONS: Thus, our data suggest that caspase-1, IL-1β and IL-18 may contribute to the inflammatory status observed in SCA and that HU treatment may not interfere in this inflammatory pathway.
OBJECTIVE AND DESIGN: This study tested the hypothesis that sickle red blood cell (SS-RBC) can induce inflammasome NLRP3 components gene expression in peripheral blood mononuclear cells (PBMCs) as well as interleukin-1β (IL-1β) and leukotriene B4 (LTB4) production. Additionally, we investigated the effect of hydroxyurea (HU) treatment in these inflammatory markers. METHODS: PBMCs from healthy donors (AA-PBMC) were challenged with intact and lysed RBCs from SCA patients (SS-RBC) and from healthy volunteers (AA-RBC). NLRP3, IL-1β, IL-18 and Caspase-1 gene expression levels were assessed by quantitative PCR (qPCR). IL-1β protein levels and LTB4 were measured by ELISA. RESULTS: We observed that lysed SS-RBC induced the expression of inflammasome NLRP3 components, but this increase was more prominent for CASP1 and IL18 expression levels. Moreover, we observed that intact SS-RBC induced higher production of IL-1β and LTB4 than lysed SS-RBC. Although SCA patients treated with HU have a reduction in NLRP3 gene expression and LTB4 production, this treatment did not modulate the expression of other inflammasome components or IL-1β production. CONCLUSIONS: Thus, our data suggest that caspase-1, IL-1β and IL-18 may contribute to the inflammatory status observed in SCA and that HU treatment may not interfere in this inflammatory pathway.
Authors: John D Belcher; Christopher J Bryant; Julia Nguyen; Paul R Bowlin; Miroslaw C Kielbik; John C Bischof; Robert P Hebbel; Gregory M Vercellotti Journal: Blood Date: 2003-01-23 Impact factor: 22.113
Authors: Fabianno F Dutra; Letícia S Alves; Danielle Rodrigues; Patricia L Fernandez; Rosane B de Oliveira; Douglas T Golenbock; Dario S Zamboni; Marcelo T Bozza Journal: Proc Natl Acad Sci U S A Date: 2014-09-15 Impact factor: 11.205
Authors: Thassila N Pitanga; Ricardo R Oliveira; Dalila L Zanette; Caroline C Guarda; Rayra P Santiago; Sanzio S Santana; Valma M L Nascimento; Jonilson B Lima; Graziele Q Carvalho; Vitor V Maffili; Magda O S Carvalho; Luiz C J Alcântara; Valéria M Borges; Marilda S Goncalves Journal: Cytokine Date: 2016-04-02 Impact factor: 3.861
Authors: Hao Xu; Nancy J Wandersee; YiHe Guo; Deron W Jones; Sandra L Holzhauer; Madelyn S Hanson; Evans Machogu; David C Brousseau; Neil Hogg; John C Densmore; Sushma Kaul; Cheryl A Hillery; Kirkwood A Pritchard Journal: Blood Date: 2014-10-22 Impact factor: 22.113
Authors: James G Taylor; Vikki G Nolan; Laurel Mendelsohn; Gregory J Kato; Mark T Gladwin; Martin H Steinberg Journal: PLoS One Date: 2008-05-07 Impact factor: 3.240